AstraZeneca is going places. The large corporation has settled its cancer drug project. Now it has sole rights over an immune boosting medicine which it bought from Inovio. Inovio gets $27.5 million...
Sanofi is making some deals that the chief executive of the company Pascal Soriot is arguing as a potential threat to the company’s financial state but Sanofi believes that buying the drugs that are...